Genenta Science S.p.A. (GNTA)

Genenta Science Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	3.69	29.79	37.24	15.47	20.14
Short-Term Investments	15.08	0	0	0	0
Cash & Cash Equivalents	18.78	29.79	37.24	15.47	20.14
Cash Growth	-36.98%	-19.99%	140.80%	-23.22%	-
Other Current Assets	2.48	1.93	1.52	1.07	0.46
Total Current Assets	21.26	31.72	38.76	16.53	20.6
Property, Plant & Equipment	0.08	0.11	0.02	0.02	0
Other Long-Term Assets	1.01	1.6	1.24	0.95	0.75
Total Long-Term Assets	1.09	1.72	1.27	0.97	0.75
Total Assets	22.35	33.44	40.03	17.5	21.35
Accounts Payable	0.47	1.19	0.19	0.56	0.57
Other Current Liabilities	1.27	0.99	0.95	1.78	1.91
Total Current Liabilities	1.74	2.18	1.14	2.33	2.49
Other Long-Term Liabilities	0.18	0.12	0.03	0.02	0.01
Total Long-Term Liabilities	0.18	0.12	0.03	0.02	0.01
Total Liabilities	1.91	2.3	1.17	2.35	2.5
Retained Earnings	-47.14	-35.47	-27.02	-21.49	-15.9
Comprehensive Income	0.23	0	0	0	0
Shareholders' Equity	20.43	31.14	38.86	15.15	18.85
Net Cash / Debt	18.78	29.79	37.24	15.47	20.14
Net Cash / Debt Growth	-36.98%	-19.99%	140.80%	-23.22%	-
Net Cash Per Share	1.03	1.64	2.47	-	-
Working Capital	19.52	29.54	37.62	14.2	18.11
Book Value Per Share	1.12	1.71	2.58	0.86	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).